Physician profile

Albert Kennedy

Memphis, TN

NPI 1558396838

$402.95

in general payments reported to CMS, 2019-2025

13 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$14.04

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Daiichi Sankyo INC. $98.41 2019-2020
Hologic Sales and Service, LLC $52.46 2019
Allergan, INC. $41.45 2019
Amgen INC. $34.55 2019-2020
Pfizer INC. $33.38 2019
Therapeuticsmd, INC. $31.88 2019
Abbvie INC. $19.94 2020
Duchesnay USA Incorporated $19.25 2019
Roche Diagnostics Corporation $18.45 2019
Bayer Healthcare Pharmaceuticals INC. $15.17 2019
Medtronic, INC. $14.04 2023 Truclear
Mylan Pharmaceuticals INC. $12.63 2019
Amag Pharmaceuticals, INC. $11.34 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Albert Kennedy

$402.95

in general payments reported 2019-2025

Years
2019-2023
Top company
Daiichi Sankyo INC.

https://glasscript.com/doctor/160885/albert-kennedy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.